Daily Bull and Bear | Market focuses on the National People's Congress Standing Committee! Hang Seng Index Futures broke through the 0.021 million level, with many bull certificates surging over 150%; china-affiliated brokerage stocks soared, with many GF
At the close, the turnover of the market reached 219.775 billion Hong Kong dollars, with a total turnover of 19.841 billion Hong Kong dollars for all warrant bull and bear certificates, accounting for 9.0% of the market turnover, of which the bull position accounts for 5.4%, and the bear position accounts for 3.6%.
FMR LLC reduces its shareholding of China Life Insurance (02628) by 0.229 million shares at approximately HKD 16.59 per share.
On November 4th, FMR LLC reduced its shareholding in China Life Insurance (02628) by 0.229 million shares, with a price of 16.5871 Hong Kong dollars per share, totaling approximately 3.79845 million Hong Kong dollars.
Unafraid of the disturbance of the US election! Hong Kong stocks have started a strong rebound mode, with consumer and financial stocks taking the lead. Which other sectors are expected to rise?
UBS Group stated that the valuation of Chinese stocks is already at a relatively low level. In the case of Trump's victory, the Chinese government may actively increase policy stimulus.
Express News | Hong Kong insurance stocks continued to rise, with New China Life Insurance up more than 10%, China Life Insurance up more than 8%, Ping An Insurance up more than 6%, PICC Group, and China Pacific Insurance up more than 4%.
Sudden Movement Spotlight | Net profits of listed insurance companies in the first three quarters have increased significantly! Mainland insurance companies have collectively risen, with ping an insurance and china life insurance both up more than 5%, and
Mainland insurance companies collectively rose. As of the time of publication, ping an insurance rose by 5.65%, closing at 51.4 Hong Kong dollars; china life insurance rose by 5.49%, closing at 17.3 Hong Kong dollars; new china life insurance rose by 4.98%, closing at 28.45 Hong Kong dollars.
Hong Kong A insurance stocks collectively strengthened, china life insurance reached the daily limit up! Pan Gongsheng: Expand the interconnection of domestic and foreign financial markets.
Gelonghui Nov 7th | Hubei Biocause Pharmaceutical's stock rose by the daily limit in the A-share market, China Life Insurance briefly hit the daily limit, New China Life Insurance rose by over 6%, Ping An Insurance rose by over 4%, The People's Insurance rose by over 3%, China Pacific Insurance rose by over 2%. In the Hong Kong stock market, China Life Insurance rose by over 6%, New China Life Insurance rose by over 5%, Ping An Insurance rose by nearly 5%. On the news front, on the 6th, the People's Bank of China held a symposium for foreign financial institutions to hear their opinions and suggestions, to further optimize the business environment, and to promote high-level opening-up of the financial industry. At the symposium, Pan Gongsheng pointed out the steady promotion of the opening-up of the financial service industry and financial market systems, and the expansion domestically.
New China Life Announces Director Appointment and Dividend
New China Life Insurance Declares Interim Dividend
China Life Insurance (02628): Each A share will distribute a cash dividend of 0.20 yuan on November 13th.
china life insurance (02628) announced the profit distribution plan of A shares for the first half of 2024, distributing cash dividends per share...
china life insurance (601628.SH): In the mid-year of 2024, a profit distribution of 2 yuan per 10 shares was declared, totaling 5.653 billion yuan distributed.
GLoannet 06 November 6th|china life insurance (601628.SH) announced that this year's 2024 semi-annual profit distribution is based on a total share capital of 28,264,705,000 shares before the implementation of the plan, with a cash dividend of 0.20 yuan per share (including tax), totaling 5.653 billion yuan in cash dividends (including tax). After this dividend distribution, the company's solvency remains at an adequate level, meeting regulatory requirements. The equity registration date is 2024/11/12, and the cash dividend payment date is 2024/11/13.
Strong Growth Potential and Strategic Positioning Lead to Buy Rating for China Life Insurance Co.
Hong Kong stocks are volatile | Mainland insurance companies collectively decline, market concerns about excessive demand for "opening red". Institutions still bullish on premium income performance.
Mainland insurance companies collectively fell. As of the time of publication, new china life insurance (01336) fell by 4.93%, closing at 27 Hong Kong dollars; china pacific insurance (02601) fell by 4.63%, closing at 26.75 Hong Kong dollars; china life insurance (02628) fell by 4.45%, closing at 16.32 Hong Kong dollars; the people's insurance (01339) fell by 1.93%, closing at 4.06 Hong Kong dollars.
CMB International: Maintaining a "buy" rating on China Life Insurance, with the target price raised to 20 Hong Kong dollars.
CICC released a research report stating that it has raised the target price of China Life Insurance (02628) H shares from 15.5 Hong Kong dollars to 20 Hong Kong dollars, maintaining a "buy" rating. The projected earnings per share for each year from 2021 to 2026 have been increased by 148%, 38%, and 31% to 4.45 yuan, 2.58 yuan, and 2.61 yuan respectively to reflect the outstanding performance and fundamental improvement in the third quarter, expressing optimism about the company's profitability in the fourth quarter. The bank expects National Life to achieve a 17% year-on-year growth in new business value this year, while indicating that investment income in the third quarter is not sustainable. In the long run,
[Brokerage Focus] ZhongYin International has raised the target price of China Life Insurance (02628) by 29%, expecting the new business value rate to continue expanding in the fourth quarter.
King Wenzhai | Zhongyin International issued a research report, indicating that China Life Insurance (02628) 3Q net income attributable to the mother increased by 17.67 times year-on-year to 66.2 billion yuan, driving the 9M24 net profit attributable to the mother to increase by 173.9% to 104.5 billion yuan, which is in the middle of the previously announced forecast range (165%-185%), meeting market expectations. The performance of 3Q net profit attributable to the mother is impressive, mainly due to the recovery of the equity market driving a significant increase in fair value changes in income and expenses. In terms of new business value, 9M24 new business value (comparable caliber) increased by +25.1% year-on-year, higher than 1H24 18.6% growth rate, indicating
Major rating agency | CICC International: Raises the target price of China Life Insurance to HK$20, with outstanding third-quarter investment performance and improved fundamentals.
Gelonghui November 6th | CICC International released a research report stating that it has raised China Life Insurance's listed in hong kong target price from 15.5 Hong Kong dollars to 20 Hong Kong dollars, maintaining a 'buy' rating, and increasing the annual earnings per share forecast for each year from 2021 to 2026 by 148%, 38%, and 31% respectively, to 4.45 yuan, 2.58 yuan, and 2.61 yuan, to reflect the company's outstanding investment performance in the third quarter and fundamental improvement. It also indicated optimism about the company's profitability in the fourth quarter. The bank expects China Life Insurance's new business value growth to increase by 17% annually this year, while pointing out that investment income in the third quarter is not sustainable. In the long term, they believe that in the fair
Capital trend statistics for the Shenzhen-Hong Kong Stock Connect (T+2) | November 6th
Capital Trend of Stock Connect through the Port of Intelligence | November 6th
Express News | The 12th meeting of the 14th National People's Congress Standing Committee: Deepening revitalization and utilization to improve the efficiency of state-owned asset management.
China Life Insurance Co (CILJF) Was Downgraded to a Sell Rating at Jefferies
Jefferies Downgrades New China Life Insurance Co., Ltd. Class H (1336) to a Sell
CHINA LIFE(2628.HK):3Q NPAT BOOSTED BY NET FAIR VALUE GAINS; EXPECT RESILIENT FULL-YEAR NBV UPSWING
No Data
No Data